Novel treatment for Acute Brain Injury (NABI) Institute
Translational Neurocritical Care & Research
NABI is a one-of-a-kind collaboration focused on improving outcomes for patients who have suffered brain injury.
NABI is the Korean word for butterfly which represents transformation, a guiding principle for the establishment and operations of the institute.
1st NABI Conference: NABI-Con 25 (April 30 ~ May 2, 2025)
We successfully hosted NABI-Con 25 from April 30 to May 2, 2025. Approximately 50 distinguished neurointensivists, scientists, and industry partners from across the United States gathered for in-depth discussions addressing the critical translational gap between basic neuroscience research and clinical neurocritical care. The conference proceedings were published in Translational Stroke Research.

Provide an innovative care model to provide timely access to expert neurointensivists across the spectrum of disease.
Development of novel therapeutics to improve outcomes for patients who have suffered from an acute brain injury.
Increase public awareness of the causes and effects of brain injury.
Enhance training for clinicians across disciplines who take care of patients with brain injury.